The upward trend of colon cancer cases in the U.S. is astronomically high—so much so that in 2021, the U.S. Preventive Services Task Force (USPSTF) updated its recommended age for colorectal cancer ...

The Cologuard Plus test is more accurate than the original Cologuard, and should be easier to mail in for stool analysis. The newest version of Cologuard, an at-home colon cancer screening test, ...

People are three times more likely to undergo at-home colon cancer screening if they're provided a free test, a new study says. About 30% of patients mailed a free stool test kit completed their ...

Health insurance companies send all kinds of things in the mail: brochures about benefits, branded items such as coasters and duffel bags, and reminders to get certain health tests done. Some have ...

Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening modalities, such as colonoscopy. However, the incidence of colorectal cancer in ...

Geneoscopy is poised to commercialize Colosense, its noninvasive, at-home multitarget stool RNA test for colorectal cancer screening. In 2025, the St. Louis, MO-based life sciences company focused on ...

A new bowel cancer screening test that can be done at home is 94 per cent accurate when compared with colonoscopies and has been submitted to the US Food and Drug Administration (FDA) for approval.

A large real-world study found that fewer than half of adults who started colorectal cancer (CRC) screening with an at-home stool test completed the recommended repeat test, creating gaps in ...

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...

In a new study aimed at identifying the best approach to promote colorectal cancer screening in adults ages 45 to 49, UCLA researchers found that simply mailing a stool-based test directly to people's ...

Colorectal cancer cases are rising among younger people, striking even folks without obvious risk factors. For nearly two decades, UC San Francisco Family Community Medicine Professor Micheal Potter, ...